Recent Posts on This Topic | See All >
ASU launching initiative for biomedical researchTags: arizona state university, asu biosignatures consortium, c-path, collaboration, igc
[Source: Phoenix Business Journal] - ASU is one step closer to finding cures and preventing diseases based on a person’s genetic make up.
Some of the state’s biggest bioscience players have been tapped to lead the consortium where reseachers will work to develop signature drugs and treatments for life-threatening illnesses, such as cancer.
The ASU Biosignatures Consortium Initiative’s goal is not only to diagnose illnesses, but also to predict the risk of disease. Biosignatures are unique to each patient’s age, sex, health and genetics.
For more information: ASU launching initiative for biomedical research
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.